University of Washington bioengineers Ying Zheng and Cole DeForest, working with Seattle Children’s infectious disease researchers, have engineered tiny blood vessels and shed light on how severe malaria infection causes red blood cells to get stuck in the bloodstream’s narrowest passageways. Their paper is published in the Jan. 17 issue of Science Advances.
On Nov. 1, bioengineer Dr. Nancy Allbritton began her role as Frank & Julie Jungers Dean of the College of Engineering at the University of Washington. In addition to her deanship at UW, she holds an appointment in the UW Department of Bioengineering, where she plans to continue her research in single-cell enzymatic assays and organ-on-a-chip technology.
University of Washington Department of Bioengineering Allan S. Hoffman Lecture Presents Kristi S. Anseth, Ph.D. [...]
https://onlinelibrary.wiley.com/doi/full/10.1002/mabi.201800242 Jingxuan Yan, Ruying Chen, Hong Zhang, James D. Bryers. Macromol Biosci. 2019 Feb;19(2):e1800242. doi: 10.1002/mabi.201800242. Abstract: mRNA vaccines have proven to [...]
UW Bioengineering faculty member Cole DeForest joined the core faculty in January 2019 as joint assistant professor of chemical engineering and bioengineering. He brings expertise in applying synthetic chemistry and materials science to the department’s biomaterials, protein engineering and regenerative medicine research.
UW Bioengineering alumnus Wayne Gombotz (M.S. ’85, Ph.D. ’88) has received the College of Engineering’s 2019 Diamond Award for Distinguished Achievement in Industry. Dr. Gombotz's work has provided the basis of many drug delivery strategies in use and development today; multiple successful therapeutic products and processes to treat cancer, infectious diseases and autoimmune diseases; and it spurred the development of the biotechnology industry in Seattle.
UW Bioengineering faculty member Jay Rubinstein was inducted to the AIMBE College of Fellows Class of 2019.
Two ideas put forth by UW's Center for Dialysis Innovation (CDI) - a next-generation wearable dialyzer and a new vascular access graft - advanced to the finals in a national competition aimed at speeding innovations in prevention, diagnosis and treatment of kidney diseases.
Bioprinted tissues with entangled vascular networks for air and blood are a major step toward 3D printing of replacement organs. Bioengineers from University of Washington and Rice University teamed to create the 3D bioprinted vascular networks and tested them in mice.
Synthetic peptide can inhibit toxicity, aggregation of protein in Alzheimer’s disease, researchers show
Researchers led by UW Department of Bioengineering Professor Valerie Daggett have developed synthetic peptides that can target and inhibit the small, toxic protein aggregates that are thought to trigger Alzheimer’s disease. The team reports their achievement in a paper published the week of April 15 in the Proceedings of the National Academy of Sciences.